Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | SUMICHEM FY26 | BAYERCROP FY26 | RALLIS FY25 | PIIND FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 30.51× | — | — | ◆ 24.24× | 24.24× +26% | |
| P/B | 4.89× | — | — | ◆ 2.86× | 2.86× +71% | |
| EV/EBITDA | 23.20× | — | — | ◆ 16.95× | 16.95× +37% | |
| Market Cap | ₹16,567 Cr | — | — | ₹32,072 Cr | ₹32,072 Cr -48% | |
| Growth | ||||||
| Revenue CAGR 3Y | -2.66% | — | 0.75% | ◆ 1.13% | 0.94% -383% | |
| Revenue CAGR 5Y | 4.13% | 5.90% | 3.41% | ◆ 7.96% | 5.76% -28% | |
| Net Income CAGR 3Y | ◆ 2.64% | — | -8.66% | 2.42% | -3.12% +185% | |
| Revenue YoY (latest Q) | -2.42% | — | ◆ 7.70% | -10.43% | -1.36% -77% | |
| Net Income YoY (latest Q) | ◆ -11.45% | — | -274.33% | -38.95% | -156.64% +93% | |
| Profitability | ||||||
| EBITDA Margin | 20.72% | 15.40% | 10.77% | ◆ 25.32% | 17.16% +21% | |
| Net Income Margin | 16.77% | 12.14% | 4.70% | ◆ 19.67% | 12.17% +38% | |
| Return on Common Equity | 17.26% | ◆ 23.70% | 6.72% | 12.16% | 14.19% +22% | |
| Return on Capital Employed | 18.60% | ◆ 25.34% | 8.33% | 11.64% | 15.10% +23% | |
| Return on Assets | ◆ 12.87% | 12.59% | 4.19% | 10.27% | 9.02% +43% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | — | 0.01× | 0.02× | 0.01× -100% | |
| Interest Coverage | 77.28× | 39.38× | 13.31× | ◆ 78.84× | 43.84× +76% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹3,238 Cr | ₹5,675 Cr | ₹2,663 Cr | ₹6,714 Cr | ₹5,017 Cr -35% | |
| Net Income | ₹543 Cr | ₹689 Cr | ₹125 Cr | ₹1,321 Cr | ₹712 Cr -24% | |
| Total Assets | ₹4,474 Cr | ₹5,699 Cr | ₹2,974 Cr | ₹13,444 Cr | ₹7,373 Cr -39% | |
| EPS | ₹10.88 | — | — | ₹87.06 | ₹87.06 -88% | |
| Book Value per Share | ₹67.91 | — | — | ₹738.85 | ₹738.85 -91% | |